Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TScan Therapeutics Reports Launch Of $125M Proposed Public Offering

Author: Benzinga Newsdesk | April 16, 2024 04:26pm

All shares of voting common stock and pre-funded warrants to be sold in the offering will be offered by TScan. The Company intends to use the net proceeds from the offering for general corporate purposes.

Posted In: TCRX